Royal Bank of Canada: Maintaining the Bausch & Lomb (BLCO.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $20.00 to $18.00.
Zhitong FinanceApr 22 23:40
Bausch & Lomb Analyst Ratings
BenzingaApr 22 23:37
RBC Capital Maintains Outperform on Bausch & Lomb, Lowers Price Target to $18
BenzingaApr 22 23:39
Bausch & Lomb Analyst Ratings
BenzingaApr 5 00:31
Benchmark Upgrades Emergent Biosolutions to Buy
Seeking AlphaMar 8 00:36
Barclays Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $18
BenzingaFeb 26 19:54
Bausch & Lomb Analyst Ratings
BenzingaFeb 26 19:53
Bausch & Lomb Analyst Ratings
BenzingaFeb 22 23:22
RBC Capital Releases a Buy Rating on Bausch + Lomb Corporation (BLCO)
TipRanksFeb 22 20:34
RBC Lifts Price Target on Bausch + Lomb to $20 From $19 After Better-Than-Expected Q4, Above-Consensus 2024 Revenue Guidance; Outperform Kept
MT NewswiresFeb 22 20:05
RBC Trims Price Target on Bausch + Lomb to $19 From $20 Ahead of Q4 2023 Report, Keeps Outperform Rating
MT NewswiresFeb 9 21:37
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Bausch + Lomb Corporation (BLCO) and Humana (HUM)
TipRanksJan 30 18:41
Evercore ISI Group Downgrades Bausch & Lomb to In-Line, Lowers Price Target to $17
BenzingaJan 5 01:08
Bausch & Lomb Analyst Ratings
BenzingaJan 5 01:06
Stifel Initiates Coverage On Bausch & Lomb With Hold Rating, Announces Price Target of $16
BenzingaDec 12, 2023 17:24
Bausch & Lomb Analyst Ratings
BenzingaDec 12, 2023 17:23
Morgan Stanley Maintains Equal-Weight on Bausch & Lomb, Lowers Price Target to $16
BenzingaDec 4, 2023 20:33
Bausch & Lomb Analyst Ratings
BenzingaDec 4, 2023 20:32
RBC Trims Price Target on Bausch + Lomb to $20 From $21 Amid Foreign-Exchange Headwinds, Keeps Outperform Rating
MT NewswiresOct 23, 2023 19:20
Morgan Stanley Maintains Equal-Weight on Bausch & Lomb, Lowers Price Target to $18.5
BenzingaOct 13, 2023 21:49
No Data
No Data